Aprea Therapeutics, Inc. Payments of Debt Issuance Costs
Aprea Therapeutics, Inc. (APRE) reported Payments of Debt Issuance Costs of $4.24 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2020-11-06
- Aprea Therapeutics, Inc. payments of debt issuance costs for the quarter ending 2019-09-30 was $3.62M.
- Aprea Therapeutics, Inc. payments of debt issuance costs for the quarter ending 2019-06-30 was $435.80K.
- Aprea Therapeutics, Inc. payments of debt issuance costs for the quarter ending 2019-03-31 was $188.83K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month |
|---|---|---|---|
| 2019-09-30 | $3.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $4.06M derived: sum of 2 quarters · filed 2020-11-06 | $4.24M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $435.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $624.62K 10-Q · filed 2020-08-11 | |
| 2019-03-31 | $188.83K 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |